• Info
  • Insider Trading

Third Rock Ventures II, L.P. - Insider Trading & Ownership

Location
29 Newbury Street, 3 Rd Floor, Boston, MA
Summary
The estimated value of insider holdings of Third Rock Ventures II, L.P. is at least $11M dollars as of September 17, 2021. Third Rock Ventures II, L.P. is the 10%+ Owner of Jounce Therapeutics, Inc. and owns shares of Jounce Therapeutics, Inc. stock worth about $10.6M. Third Rock Ventures II, L.P. is the 10%+ Owner of Revolution Medicines, Inc. and owns shares of Revolution Medicines, Inc. (RVMD) stock worth about $349K.
Signature
/s/ Kevin Gillis, Chief Operating Officer of TRV GP II, LLC, general partner of Third Rock Ventures GP II, L.P., general partner of Third Rock Ventures II, L.P.
All Insider Reports
All Insider Reports

Notify me when Third Rock Ventures II, L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Third Rock Ventures II, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
JNCE Jounce Therapeutics, Inc. 10%+ Owner $10.6M Sep 15, 2021
RVMD, RVMDW Revolution Medicines, Inc. 10%+ Owner $349K Jun 3, 2021

Insider Transactions Reported by Third Rock Ventures II, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.